Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 13/20 | 0.56 |
| ▸ | CA2 | P00918 | 13/20 | 0.56 |
| ▸ | CA9 | Q16790 | 9/20 | 0.48 |
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA7 | P43166 | 4/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3050404 | 0.93 | CA1 (0.58) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19733 | 0.92 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL16108599 | 0.92 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28123592 | 0.92 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3047127 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3053415 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11832630 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL29181652 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL1049786 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL7718044 | 0.91 | CA1 (0.59) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4590777-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC Materials LLC (US) | 2025-07-30 | — | — | EP | claimed |
| WO-2024064127-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC MATERIALS LLC (US) | 2024-03-28 | — | — | WO | claimed |
| US-20240101865-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC MATERIALS LLC | 2024-03-28 | — | — | US | claimed |
| EP-4590777-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC Materials LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| WO-2024064127-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC MATERIALS LLC (US) | 2024-03-28 | — | — | WO | disclosed |
| US-20240101865-A1 | TUNGSTEN CMP COMPOSITION INCLUDING A SULFUR CONTAINING ANIONIC SURFACTANT | CMC MATERIALS LLC | 2024-03-28 | — | — | US | disclosed |
| US-20230343965-A1 | SECONDARY BATTERY | MURATA MANUFACTURING CO (JP) | 2023-10-26 | — | — | US | disclosed |
| US-8460821-B2 | Non-aqueous electrolyte secondary battery, non-aqueous electrolyte, and method for fabricating non-aqueous electrolyte secondary battery | GS YUASA INTERNATIONAL LTD. (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20110318655-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, NON-AQUEOUS ELECTROLYTE, AND METHOD FOR FABRICATNG NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | GS YUASA INTERNATIONAL LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20100222580-A1 | Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content | MERCK PATENT GMBH (DE) | 2010-09-02 | — | — | US | disclosed |
| EP-1828142-B1 | METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT | MERCK PATENT GMBH (DE) | 2010-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222580-A1 | Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content | STS, MRPS35, ARSA | CA1 3642/4885CA2 2132/4885CA9 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.